BackAnthera Pharmaceuticals Overview

Anthera Pharmaceuticals Other Current Assets

Anthera Pharmaceuticals's other current assets is $650K.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$653000.00
69.21% YoYΔ $-1.47M vs prior year quarter

Peer average / median

Loading

Anthera Pharmaceuticals Other Current Assets History

Loading

Anthera Pharmaceuticals vs. peers: Other Current Assets Comparison

Loading

Anthera Pharmaceuticals Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Anthera Pharmaceuticals (ANTH) FAQ

Anthera Pharmaceuticals (ANTH) currently reports a other current assets of $650K as of March 2018. That compares with $2.1M in the prior-year period — down 69.2% year over year. Use the charts on this page to explore Anthera Pharmaceuticals's other current assets history and peer comparisons.

Anthera Pharmaceuticals's other current assets decreased from $2.1M to $650K — a 69.2% year-over-year decrease (period ending March 2018). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Anthera Pharmaceuticals reported $650K in other current assets as of March 2018. That compares with $2.1M in the prior-year period — down 69.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $650K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Anthera Pharmaceuticals, and consider following ANTH for alerts when major investors trade the stock.

Anthera Pharmaceuticals is classified in the Healthcare sector. On other current assets, it currently shows $650K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ANTH with unrelated industries.